Progression of diabetic retinopathy during improved metabolic control may be treated with reduced insulin dosage and/or somatostatin analogue administration

Progression of diabetic retinopathy during improved metabolic control may be treated with reduced insulin dosage and/or somatostatin analogue administration – a case report

Published:2005-04 Issue:2 Volume:15 Page:130-135
ISSN:1096-6374
Container-title:Growth Hormone & IGF Research
language:en
Short-container-title:Growth Hormone & IGF Research

Author:

Chantelau E.,Frystyk J.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference26 articles.

1. Classification of growth hormone insensitivity syndrome;Laron;J. Pediatr.,1993

2. For the rhIGF-I in IDDM study group: cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type I Diabetes;Thrailkill;Diabetes Care,1999

3. Diabetes Control and Complications Trial Research Group, Early worsening of diabetic retinopathy in the diabetes control and complications trial, Arch. Ophthalmol. 116 (1998) 874–886

4. Evidence that upregulation of serum IGF-I concentration can trigger acceleration of diabetic retinopathy;Chantelau;Br. J. Ophthalmol.,1998

5. What may be gained from standard photocoagulation during early worsening of diabetic retinopathy? An observational study in type-1 diabetic patients after tightening of glycaemic control;Chantelau;Diabetes Metab.,2001

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of risk factors for hypoglycemia in patients with gastrointestinal bleeding induced by somatostatin for injection and establishment of the prediction model;Int. Journal of Clinical Pharmacology and Therapeutics;2024-01-01

2. Effect of Insulin-Like Growth Factor-1 on Diabetic Retinopathy in Pubertal Age Patients With Type 1 Diabetes;Asia-Pacific Journal of Ophthalmology;2019-07

3. Autophagy in Diabetic Retinopathy;Current Neuropharmacology;2016-10-31

4. Insulin;Meyler's Side Effects of Drugs;2016

5. Current nanotechnology approaches for the treatment and management of diabetic retinopathy;European Journal of Pharmaceutics and Biopharmaceutics;2015-09